Company Filing History:
Years Active: 2017-2024
Title: Binyamin Schwartz: Innovator in Inhalation Technology
Introduction
Binyamin Schwartz is a notable inventor based in Sde Eliezer, Israel. He has made significant contributions to the field of inhalation technology, holding a total of 17 patents. His innovative designs aim to enhance the delivery of substances through inhalers, improving user experience and efficacy.
Latest Patents
Among his latest patents is the "Replaceable Flow Tract for an Inhaler." This invention provides a replaceable flow tract designed for inhaler devices that deliver substances to users. The design includes a housing that accommodates the flow tract and a construct containing source material for substance release. The flow tract features a conduit with multiple openings, including an elastic sealing member that ensures a secure fit against the construct.
Another significant patent is the "Source Material Cartridge with Temperature-Controlled Sealant." This device is engineered to release substances from source material effectively. It comprises a housing with fixed source material sections and airflow paths, each equipped with blocking elements. An actuator is included to unblock airflow paths, allowing air to flow through the selected source material section.
Career Highlights
Binyamin Schwartz is currently associated with Syqe Medical Ltd., a company focused on advancing inhalation technology. His work has been pivotal in developing innovative solutions that cater to the needs of users requiring inhalation therapies.
Collaborations
Throughout his career, Binyamin has collaborated with talented individuals such as Aaron Schorr and Perry Davidson. These partnerships have contributed to the successful development of his patented technologies.
Conclusion
Binyamin Schwartz stands out as a prominent inventor in the field of inhalation technology, with a strong portfolio of patents that reflect his innovative spirit. His contributions continue to shape the future of inhalation devices, enhancing the delivery of essential substances to users.